πŸ‡ΊπŸ‡Έ FDA
Patent

US 8853255

3-phenoxymethylpyrrolidine compounds

granted A61KA61K31/40A61K31/4025

Quick answer

US patent 8853255 (3-phenoxymethylpyrrolidine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/40, A61K31/4025, A61P, A61P13/00